APA (7th ed.) Citation

J, P., K, V., A, B., & JS, L. (2024). The Use of Biologic Agents for the Treatment of Cutaneous Immune-Related Adverse Events from Immune Checkpoint Inhibitors: A Review of Reported Cases. American journal of clinical dermatology, 25(4), 595. https://doi.org/10.1007/s40257-024-00866-z

Chicago Style (17th ed.) Citation

J, Pach, Valido K, Belzer A, and Leventhal JS. "The Use of Biologic Agents for the Treatment of Cutaneous Immune-Related Adverse Events from Immune Checkpoint Inhibitors: A Review of Reported Cases." American Journal of Clinical Dermatology 25, no. 4 (2024): 595. https://doi.org/10.1007/s40257-024-00866-z.

MLA (9th ed.) Citation

J, Pach, et al. "The Use of Biologic Agents for the Treatment of Cutaneous Immune-Related Adverse Events from Immune Checkpoint Inhibitors: A Review of Reported Cases." American Journal of Clinical Dermatology, vol. 25, no. 4, 2024, p. 595, https://doi.org/10.1007/s40257-024-00866-z.